Daiwa Securities Group
RPTX

Daiwa Securities Group’s Repare Therapeutics RPTX Stock Holding History

Daiwa Securities Group’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-127
Closed -$2K – 1383
2023
Q3 		$2K Hold
127
– – ﹤0.01% 1226
2023
Q2 		$1K Hold
127
– – ﹤0.01% 1295
2023
Q1 		$1K Hold
127
– – ﹤0.01% 1279
2022
Q4 		$2K Hold
127
– – ﹤0.01% 1236
2022
Q3 		$2K Sell
127
-5,745
-98% -$74K ﹤0.01% 1246
2022
Q2 		$82K Buy
5,872
+5,745
+4,524% +$67.7K ﹤0.01% 1043
2022
Q1 		$2K Hold
127
– – ﹤0.01% 1269
2021
Q4 		$3K Hold
127
– – ﹤0.01% 1257
2021
Q3 		$3K Buy
127
+58
+84% +$1.87K ﹤0.01% 1226
2021
Q2 		$2K Hold
69
– – ﹤0.01% 1154
2021
Q1 		$2K Hold
69
– – ﹤0.01% 1160
2020
Q4 		$2K Buy
+69
New +$2.06K ﹤0.01% 1136

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Daiwa Securities Group's RPTX Position: Q4 2023 in Review

Daiwa Securities Group sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 127 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in RPTX in Q4 2020 and held it in 12 quarters. The position peaked at $82K in Q2 2022. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

  • Daiwa Securities Group reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 127 Repare Therapeutics shares in Q4 2023, an estimated $2K.
  • Daiwa Securities Group first reported a position in Repare Therapeutics in Q4 2020 and held it in 12 quarters.
  • Daiwa Securities Group's Repare Therapeutics position peaked at $82K in Q2 2022.
  • 69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.